RxDoctor Payments Data

Gina Pontius, MD

Family Medicine · Palmyra, MONPI 1871793257

Payments from drug & device makers

$2,392in general payments, 2019–2025

Across 144 payments — averaging $16.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$467
  • AstraZeneca$300
  • Novo Nordisk$244
  • Otsuka America Pharmaceutical, Inc.$237
  • Novartis$197
  • Amgen$163
  • plus $785 from 18 others

What the payments were for

  • Food & beverage$2,392100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,392 in reported general payments places this provider in the 75th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$8,063
Medicare patients
40
Services billed
479

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide98$130,536
JanuviaSitagliptin Phosphate95$80,712
EliquisApixaban74$59,848
JardianceEmpagliflozin46$45,390
TrulicityDulaglutide21$31,482
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$19,450
BriviactBrivaracetam27$19,264
MounjaroTirzepatide17$16,736
XareltoRivaroxaban29$12,184
MyrbetriqMirabegron16$12,006
Lantus SolostarInsulin Glargine,hum.Rec.Anlog63$11,128
Tresiba Flextouch U-100Insulin Degludec16$10,552
Gabapentin281$6,429
Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt12$6,386
ArexvyRsvpref3 Antigen/As01e/Pf19$5,529

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$244$130,53698 claims
PfizerEliquis, Abrysvo$45$63,11586 claims
Lilly USA, LLCTrulicity, Mounjaro$144$48,21838 claims
Boehringer IngelheimJardiance$86$45,39046 claims
AstraZenecaBreztri Aerosphere$300$19,45015 claims
AbbVieSynthroid$467$1,50943 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Palmyra

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →